Utilization of low crude protein diets and probiotics to support gut health and function in weaned piglets
Utilization of low crude protein diets and probiotics to support gut health and function in weaned piglets
批准号:
520195-2017
负责人:
Nyachoti, CharlesMartin
金额:
$3.94万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
中文摘要
仔猪断奶后腹泻会降低仔猪的生长性能,从而给养猪业造成经济损失。传统上,养猪业通过使用含有高度可消化和专门成分的起始饲料来减轻这些损失,例如喷雾干燥的猪血浆和亚治疗水平的抗生素作为生长促进剂。然而,公众强烈要求停止在猪饲料中使用动物产品和抗生素,因为担心这些产品对人类健康构成风险。因此,养猪业对确定有效,安全和环境友好的营养干预措施非常感兴趣,这些干预措施可以取代饲料中抗生素的使用。现有证据表明,低粗蛋白-氨基酸补充日粮(LCP-AA)可作为整体策略的一部分,以调节断奶仔猪的肠道发育,微生物群落和免疫反应。然而,这是至关重要的,这样的饮食是精心配制,以避免氨基酸缺乏症。此外,LCP-AA饮食和其他添加剂(如益生菌)之间可能存在协同效应。因此,将进行研究以确定可能限制饲喂LCP-AA饲料的猪的性能的氨基酸需求。将研究LCP-AA和益生菌之间协同相互作用的潜力,以确定预防仔猪腹泻的有效治疗组合。免疫激发模型将用于有效测试这些干预措施在支持仔猪肠道健康和功能方面的潜力。该项目的结果将有助于为断奶仔猪制定可持续的营养管理方案,从而帮助加拿大养猪业适应饲料中抗生素使用的新限制,以保持在国际市场上的竞争力。
英文摘要
Post-weaning diarrhea in piglets reduces growth performance and therefore causes economic losses in the swine industry. Traditionally, the swine industry has mitigated these losses by utilizing starter diets containing highly digestible and specialized ingredients such as spray dried porcine plasma and sub-therapeutic levels of antibiotics as growth promoters. However, there is intense public pressure to discontinue the use of animal products and antibiotics in pig diets for fear that these products pose a risk to human health. Thus, the swine industry is keenly interested in identifying effective, safe and environmentally friendly nutritional interventions that could replace the use of in-feed antibiotics. Existing evidence suggests that low crude protein-amino acid supplemented diets (LCP-AA) could be used as part of the overall strategy to modulate intestinal development, microbial communities, and immune response in weaned piglets. However, it is critical that such diets are carefully formulated to avoid amino acid deficiencies. Also, there may be synergistic effects between LCP-AA diets and other additives such as probiotics. Therefore, research will be conducted to determine requirements of amino acids that are likely to limit performance of pigs fed LCP-AA diets. The potential for synergistic interactions between LCP-AA and probiotics will be studied with a view of identifying a combination of effective therapies for prevention of piglet diarrhea. Immune challenge models will be used to effectively test the potential of these interventions to support gut health and function in piglets. Results of the project will be useful in developing sustainable nutritional management options for weaned pigs thus helping the Canadian swine industry to adapt to new restrictions regarding in-feed antibiotic usage so as to remain competitive at the international market place.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Natural means of controlling gut health and optimizing performance in early-weaned pigs: Research on a new generation enzyme-antibody supplement.
-
批准号:326385-2005
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$3.29万
-
财政年份:2009
-
负责人:Nyachoti, CharlesMartin
-
依托单位:
Natural means of controlling gut health and optimizing performance in early-weaned pigs: Research on a new generation enzyme-antibody supplement.
-
批准号:326385-2005
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$3.47万
-
财政年份:2008
-
负责人:Nyachoti, CharlesMartin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向TREM2low小胶质细胞重构脊髓Glu/GABA稳态的机制及干预策略研究
-
批准号:82571569
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:满韦韬
-
依托单位:
骨髓微环境中正常造血干/祖细胞新亚群IL7Rα(-)LSK(low)细胞延缓急性髓系白血病进程的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王震毅
-
依托单位:
MSCEN聚集体抑制CD127low单核细胞铜死亡治疗SLE 的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:耿林玉
-
依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
-
批准号:82371631
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:卢慕峻
-
依托单位:
Ni-20Cr合金梯度纳米结构的低温构筑及其腐蚀行为研究
-
批准号:52301123
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:郭晓开
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
新型PDL1+CXCR2low中性粒细胞在脉络膜新生血管中的作用及机制研究
-
批准号:82271095
-
项目类别:面上项目
-
资助金额:56万元
-
批准年份:2022
-
负责人:柳夏林
-
依托单位:
CD9+CD55low脂肪前体细胞介导高脂诱导脂肪组织炎症和2型糖尿病的作用和机制研究
-
批准号:82270883
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:毕艳
-
依托单位:
CD21low/-CD23-B细胞亚群在间质干细胞治疗慢性移植物抗宿主病中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈小湧
-
依托单位:
探究Msi1+Lgr5neg/low肠道干细胞抵抗辐射并驱动肠上皮再生的新机制
-
批准号:82270588
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:吕聪
-
依托单位: